Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ajo.2020.08.017 | DOI Listing |
Am J Ophthalmol
January 2025
Universidad Autonoma de Bucaramanga UNAB, Bucaramanga, Colombia.
Am J Ophthalmol
January 2025
Cathedral Eye Clinic, Belfast, United Kingdom.
J Arrhythm
February 2025
Department of Cardiology and Clinical Examination, Faculty of Medicine Oita University Yufu Japan.
Urology
December 2024
Urology Service, Hospital del Trabajador, Santiago, Chile. Electronic address:
JAMA Ophthalmol
January 2025
Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.
Importance: In-office suprachoroidal viscopexy (SCVEXY) is a relatively new procedure for rhegmatogenous retinal detachment (RRD), but minimal information is available regarding outcomes and safety.
Objective: To report outcomes with in-office SCVEXY for primary acute RRD.
Design, Setting, And Participants: This retrospective case series was conducted at St Michael's Hospital in Toronto, Ontario, Canada from June 2023 to February 2024 among consecutive patients with primary acute RRDs who presented with retinal tears that were reachable with the current in-office SCVEXY technique in the temporal or nasal retina.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!